Abstract
Employing selenocysteine-containing protein fragments to form the amide bond between respective protein fragments significantly extends current capabilities of the widely used protein engineering method, expressed protein ligation. Selenocysteine-mediated ligation is noteworthy for its high yield and efficiency. However, it has so far been restricted to solid-phase synthesized seleno-peptides and thus constrained by where the selenocysteine can be positioned. Here we employ heterologously expressed seleno-fragments to overcome the placement and size restrictions in selenocysteine-mediated chemical ligation. Following ligation, the selenocysteine can be deselenized into an alanine or serine resulting in non-selenoproteins. This greatly extends the flexibility in selecting the conjugation site in expressed protein ligations with no influence on native cysteines. Furthermore, the selenocysteine can be used to selectively introduce site-specific protein modifications. Therefore, selenocysteine-mediated expressed protein ligation simplifies incorporation of posttranslational modifications into the protein scaffold.
Introduction
Native chemical ligation (NCL) is a biosynthetic method for protein preparation that relies upon an amide-forming reaction to generate proteins from their respective fragments.1–3 Many proteins require NCL preparation due to their toxicity to cells, their inability to fold or assemble correctly in the host, or because their preparation involves post-translational modifications that cannot be carried out by the host or in cell-free systems. The majority of NCL reactions are accomplished via expressed protein ligation (EPL) in which at least one of the fragments to be ligated was prepared by heterologous expression. The ligation is driven by a cysteine-mediated attack on a protein fragment terminating with a thioester.4,5 EPL is widely used but suffers from several limitations. First the ligation efficiency can be low, particularly for large fragments, because the reaction needs to be carried out in a slightly basic pH to allow Cys deprotonation, which unfortunately also accelerates the thioester hydrolysis. Second, the cysteine cannot be desulfurized selectively if the protein contains other cysteines that are necessary for its function. Cysteine may have structural, catalytic, or signaling functions and is often necessary for function. Third, since the cysteine is necessary for ligation it restricts the choice of ligation site or alternatively leaves a cysteine instead of the original residue, introducing a mutation. However, the ligation efficiency can be significantly boosted by using selenocysteine (Sec, U), which is a better nucleophile than cysteine.6,7 Furthermore, Sec’s low pKa (~5.2) allows the reaction to occur at lower pH values thereby minimizing undesired side reactions including competing thioester hydrolysis. Sec-mediated ligation also offers much greater flexibility in the choice of ligation site because, following ligation, the Sec can be selectively converted into an alanine or serine under mild conditions.8–11 Due to the abundance of these amino acids it is straightforward to generate the protein of interest with the desired sequence with no trace of the ligation. The distinct advantage of Sec deselenization to Ala is that it is compatible with the presence of cysteines in the target protein. In contrast, Cys desulfurization to Ala will eliminate all cysteines indiscriminately, including those that are indispensable for function.8,9,12 Moreover, due to its specialized chemistry, Sec can be specifically manipulated while leaving any of the 20 canonical amino acids unaffected.13–17 Therefore, Sec’s chemical reactivity can be further exploited to specifically label the protein via selenylsulfide (Se-S), diselenide (Se-Se), and selenoether (C-Se-C) bonds, or via conversion to dehydroalanine (Fig. 1). Dehydroalanine is a highly reactive electrophile that readily reacts with nucleophiles, linking them permanently to the protein of interest.
Figure 1.
(a) Principle of expressed selenoprotein ligation (ESL). The seleno-fragment, fused with MBP, is expressed in E. coli in selenocystine enriched medium. The complementary thioester protein fragment is prepared via intein technology. TEV protease cleaves MBP from the seleno-fragment and the protein of interest (POI) is then spontaneously generated through amide bond formation. (b) Applications of Sec-mediated ligation. Panels C-H: ESL preparation of SelM. (c) Design of SelM fragments. Red: thioester fragment; Green: seleno-fragment; Yellow: sulfur atom; Orange: selenium atom. (d) The design of thioester (SelMNT) and seleno (SelMCT) fragments. SelM’s ER targeting sequence (residues 1 to 24) was omitted as it is cleaved in vivo. (e) SelM ligation at 25 °C and pH 7.0 monitored by SDS-PAGE under reducing conditions: Lane 1: MBP-SelMCT; lane 2: same as lane 1 but after TEV protease cleavage; lane 3: MBP-SelMNT-VMA; lane 4: MBP-SelMNT thioester following cleavage of MBP-SelMNT-VMA with thiols and subsequent purification; lanes 5-7 the formation of SelM monitored on days 0, 1, and 2. Lane M: molecular mass standards. SelMNT cannot be detected because of its 2 kDa mass. (f) Deconvoluted ESI-MS of intact SelM. (g) ESI-MS spectrum of the SelM peptide containing the Sec residue alkylated with iodoacetamide (purple star). (h) Tandem MS sequencing of the peptide from panel G confirms Sec’s presence in SelM. Fragment ions that contain Sec are colored red. (i) Superimposed CD spectra of SelM, before and after refolding, and SelM U48C prepared by heterologous expression.
The power of Sec-mediated over Cys-mediated ligation was noted by seminal work on native chemical ligation.18,19 Yet, despite its many advantages, it was demonstrated for only a handful of proteins because of restrictions on where the Sec can be incorporated. This is because current methods rely exclusively on seleno-fragments prepared by solid-phase peptide synthesis, a powerful technique yet one that is constrained by peptide size and properties.20,21 Accordingly, placement of Sec at loci distant from the C-terminus is technically demanding, and the majority of Sec-driven EPL reactions were carried out with short peptides. Indeed, due to these limits only one selenoprotein was synthesized with a Sec-peptide longer than 25-mer22 and just one native selenoproteins has been reported so far.23 To remove these constraints, and to allow high yield as well as readily accessible Sec-mediated ligation, we developed a broadly applicable method employing heterologous expression for the preparation of Sec-containing protein fragments (Fig. 1), which we have abbreviated as Sec-EPL. In Sec-EPL, seleno-fragments are prepared by heterologous expression and stabilized by a fusion partner. The seleno-fragment is then released immediately prior to ligation to minimize potential aggregation. This assists Sec-driven EPL ligations, particularly those with large or insoluble fragments. The procedure is simple, cost-effective, and offers high-yield preparation of both selenoproteins and conventional (i.e. without selenium) targets. The primary advantage is that a broad range of the seleno-containing fragments can be generated and subsequently ligated. This facilitates the preparation of demanding targets such as large proteins. It is also suitable for introducing multiple posttranslational modifications by manipulating both Sec and Cys in proteins for site-specific dual-labeling.
Results
Principles of Selenocysteine - Expressed Protein Ligation
The challenge in heterologous expression of protein fragments with Sec is that while Sec is a genetically encoded amino acid, its incorporation into proteins is distinct from that of the 20 canonical amino acids.24,25 Uniquely, Sec insertion requires a dedicated suite of proteins and a structural element in the protein mRNA to reprogram the opal codon UGA to encode for Sec. While it is possible to utilize the native cellular machinery to prepare selenoproteins the incorporation efficiency remains low due to the opal codon being decoded as a termination signal.26 More recently, engineering of the Sec-specific tRNA removed the restrictions on the transcribed sequence, affording a flexible platform for heterologous expression of selenoproteins with yield constantly improving.27–30 Other methods include manipulations of unconventional amino acids inserted using recombinant systems for amber-codon suppression14,31, the substitution of all sulfur atoms into selenium32, linking the Sec enzymatically before a Lys or Arg33 and chemical synthesis.34 Nevertheless, placement of Sec at a desired position in a protein remains more demanding than routine protein work and so far suffers from low yield. Since our goal is to readily prepare Sec-fragments with high yield, we have opted to prepare seleno-fragments using a method in which Sec is incorporated by misloading the cysteinyl-tRNA with Sec (Fig. 1a) using defined E. coli growth medium supplemented with selenocystine.35 Our procedure was adapted from protocols developed for enrichment of Sec and selenomethionine in proteins for crystallographic phasing36,37 but simplified to minimize growth media exchange and optimize yield. Similar to those reports our modified procedure leads to about 90% substitution of all Cys residues to Sec (examples are shown in the next section). For selective placement of Sec in only one location in the protein, the Sec-fragment cannot contain Cys residues because the Sec incorporation method results in a global replacement of all Cys with Sec. However, Cys residues can be placed without restrictions in the complementary fragment. The seleno-fragment is expressed fused with maltose binding protein (MBP). This inhibits its aggregation, increases both yield and solubility and offers an affinity tag for purification. Using fusion partners allows the expression of diverse seleno-fragments at high yield and removes the constraint on their size or properties. However, as shown in Figure 1a, in order for the ligation to take place, the Sec must be the first residue at the N-terminus of the seleno-fragment, so that the selenolate can attack the thioester bond of the complementary protein fragment to generate the amide bond. To that end, we demonstrate that the seleno-fragment can be cleaved directly before the Sec, using tobacco etch virus (TEV) protease (see later). Once freed, the exposed Sec attacks the thioester fragment and the ligation proceeds through a spontaneous Se→N acyl shift to form the protein of interest.5 Thus, it is key to Sec-EPL success that the seleno-fragment is released just prior to ligation to avoid aggregation and that the TEV protease releases the seleno-fragment with a free N-terminus Sec. Depending on the needs for subsequent purification steps, the TEV protease can be present during or removed ahead of the ligation. An advantage of retaining the TEV protease is that the release of the Sec-fragment is immediately followed by a ligation, which minimizes the chances of aggregation of unstable protein fragments. In what follows, we demonstrate the broad applicability of our Sec-EPL method, as summarized in Figure 1b.
Sec-EPL of Selenoproteins
First, Sec-EPL allows the preparation of selenoproteins, a family of enzymes that is predominantly involved in signal transduction and detoxification pathways.24,25,38 Despite their physiological importance, many of their functions remain unknown as their specialized biosynthesis renders them difficult to obtain for characterization (see above).24 The largest class of selenoproteins possesses a thioredoxin (Trx) fold. It is an early evolutionary tertiary protein structure that is commonly found in enzymes that catalyze a broad spectrum of reactions, such as oxidation, reduction or thiol disulfide exchange.39,40 In humans, members of this class (SelH, SelM, SelT, SelV, SelW, and Sep15) are implicated in signal transduction and regulation of gene expression.41 However, so far, no Sec-containing species from this class has been characterized in vitro. We made selenoprotein M (SelM) as a representative member of the group. SelM was linked to obesity but its precise function or protein partners remain unknown.24 Human SelM contains Sec at the 48th residue out of 145, in a Cys-X-X-Sec redox motif located on a loop adjacent to the first beta sheet (where X stands for any amino acid; Fig. 1c).42 Figure 1d and S1 detail the construction of the two fragments for ligation: MBP-SelMCT and MBP-SelMNT-thioester. Sec was incorporated using a modified cysteinyl-tRNA misloading protocol (for details see supporting information). Following purification, the seleno-fragment SelMCT was cleaved from its MBP partner by TEV protease. The TEV protease was selected due to its tolerance toward small amino acids at its recognition site ENLYFQ/P1′ (where P1′ stands for any canonical amino acid except P).43 We demonstrated that TEV protease cleaves the peptide bond between Q and U leaving a fragment with Sec at the N-terminus that is free to react with the thioester fragment (Fig. 1e, S2-S4). The thioester fragment was generated by standard intein technology using Saccharomyces cerevisiae Vacuolar Membrane ATPase (VMA1) intein (Fig. S5).44 The ligation reaction under native conditions was over 90% completed after one day (Fig. 1e, S6-S7). SelM was further purified to homogeneity and its identity confirmed by intact protein ESI-MS and tandem mass sequencing (Fig. 1f-h and S8). The presence of Sec was confirmed from the isotopic distribution of the seleno-peptide VETCGGUQLNR (generated by a trypsin digestion) and its subsequent sequencing by tandem mass spectrometry. The resulting SelM is primarily the Sec-containing form as judged by intact ESI-MS (Fig. 1f). This is because even though a slight amount of Cys-containing fragment is present during the ligation, at pH <7 the Sec-fragment is at least 10 times more reactive than the Cys-fragment.5 We found in multiple systems that MBP was helpful for increasing the yield and solubility. Other fusion proteins worked well but MBP was the most robust. Furthermore, pMAL vectors and our modified pMAL cloning vector (Fig. S1) were the most robust for achieving high Sec incorporation, including multiple Sec (Fig. S9). The ligation yield is compatible with that needed for biochemical and structural characterization: 10 mg of SelM from ligation utilizing MBP-SelMNT-VMA expressed in 6 L LB medium and MBP-SelMCT from 2 L defined growth medium. The circular dichroism (CD) spectra of SelM before and after refolding, and that of SelM U48C prepared by conventional heterologous expression (Fig. S10) exhibited a high degree of similarity when superimposed (Fig. 1i). This indicates that after ligation, SelM folded spontaneously to adopt its native fold.
In addition, we have prepared selenoprotein W (SelW), a cell cycle regulator that interacts with signaling proteins.45,46 Like SelM its enzymatic function is yet unknown. In contrast to SelM, in SelW the active site is stabilized by an extensive network of aromatic residues.47 Consequently, its preparation requires refolding (Fig. S11-S16). Human and other mammalian SelW have been reported to be glutathiolated on their non-active cysteines.34,48 Thus, in preparation for activity assays and studies of SelW’s interactions with protein partners we selected Gallus gallus SelW, which contains only one Cys at the active site.
Sec-EPL of Non-selenoproteins
Importantly, Sec-EPL can generate a wide range of proteins without introducing mutations because the Sec can be readily and selectively deselenized into either serine or alanine.10,11 Therefore, it is possible to convert Sec into an abundant amino acid, leaving no trace of the original ligation method. The ligation site then can be selected to increase the probability of the fragments reacting, such as loops and other surface accessible regions. To demonstrate the conversion and its specificity, we prepared a Sec-containing form of E. coli Trx using residue 94 as the ligation site (Fig. 2a-c, S17-S22; figures show Trx samples following its purification). Trx A94U was converted to native Trx by treating it with 200-fold excess tris(2-carboxyethyl)phosphine (TCEP) and dithiothreitol (DTT) under anaerobic conditions to promote deselenization of Sec into alanine (Fig. 2d, S23). While under aerobic conditions Sec turned into Ser (Fig. S24). Trx has two catalytic Cys residues, which were not affected by this mild treatment. The disulfide reductase activity of Trx formed by deselenization was comparable to that of Trx prepared by heterologous expression (Fig. 2e, S25-S26).
Figure 2.
ESL can be used to generate non-selenoproteins and to introduce a unique site for labeling. Panels a-d) Chemical ligation of E. coli Trx with Sec at position 94 and subsequent deselenization to form wild-type Trx. (a) The structure of Trx A94U based on PDB entry 2TRX. Red: thioester fragment; Green: seleno-fragment; Yellow: sulfur atoms; Orange: selenium atom. (b) The design of thioester (TrxNT) and seleno (TrxCT) fragments. (c) Deconvoluted ESI-MS of Trx A94U. (d) Deconvoluted ESI-MS of wild-type Trx generated by deselenization of Sec to Ala (the * denotes Trx A94S). (e) The enzymatic activity of Trx generated by deselenization and that of Trx prepared by heterologous expression are similar as measured by insulin turbidity assays. Data represent mean±s.d. (n=3). (f) Labelling of Trx A94U with a thiophosphate (the peak marked with ** is a contamination from the commercial thiophosphate). (g) Conjugation of Trx A94U to ubiquitin G76C via the formation of a selenylsulfide bond. (h) Conjugation of Trx A94U to ubiquitin G76U via the formation of a diselenide bond. Panels i-j) Due to Sec’s low pKa it can be selectively alkylated. (i) A mixture of ubiquitin G76C and ubiquitin G76U prior to alkylation. (j) The same sample from panel i alkylated with MM(PEG)24. Only ubiquitin G76U was alkylated.
Site-specific Conjugation of Post-translational Modifications
Subsequently, Trx A94U was used to selectively introduce post-translational modifications and for conjugating proteins. Trx A94U provides an excellent test case because its catalytic cysteines are highly reactive and can in theory be modified as well. A phosphate group was introduced selectively on U94 by reacting reduced Trx A94U with thiophosphate (Fig. 2f, S27). We next tested the ability to link proteins via the Sec in a reversible fashion. Trx A94U was conjugated to ubiquitin G76C via a selenylsulfide (Se-S) bond, and to ubiquitin G76U via a diselenide (Se-Se) bond (Fig. 2g-h, S28). Such conjugations are reversible and can be conveniently manipulated in a selective manner. The diselenide bond has a lower redox potential than that of disulfide bond and can be retained under mild reducing conditions for downstream applications such as activity assays or for keeping the diselenide linkage while reducing undesired disulfide bonds.49 Finally, we also demonstrate that it is possible to selectively target Sec over Cys in a mixture of ubiquitin G76C and ubiquitin G76U (Fig. 2i-j). Ubiquitin G76U formed a stable selenoether (C-Se-C) bond with the alkylating reagent methyl-PEG-maleimide, while ubiquitin G76C was unmodified. Overall, these examples demonstrate the well-documented ability to selectively modify Sec, even when cysteines are present,15 while further corroborating that no side reactions, such as Sec elimination, takes place (as detected by mass spectrometry).
Another promising Sec-EPL application is to promote selenium elimination from Sec to form dehydroalanine, which serves as an electrophilic site for Michael addition reactions, typically with thiol nucleophiles. Dehydroalanine provides a unique site to introduce conjugates that closely resemble the proteins original biological modifications.12,50 In addition, a biocompatible reaction that forms C-C bonds has recently vastly diversified the kind of protein modifications that can be attached to dehydroalanine.51 Dehydroalanine is typically incorporated into protein by desulfurization of cysteine,12 via overoxidation of nonconventional amino acids, or phosphate removal from a phosphoserine.14,52,53 Yet, introducing dehydroalanine chemoselectively remains challenging when proteins have multiple cysteines. We tested Sec deselenization by bis-alkylation-elimination using α,α′-di-bromo-adipyl(bis)amide (DBAA), which was previously reported to be not only as being highly efficient for cysteine desulfurization but also as having the least side reactions.12 It was also recently used to promote dehydroalanine formation chemoselectively from Sec in peptides without modifying other amino acids. However, the reactions were carried out at very low pH and under denaturing conditions that are incompatible with labeling of most proteins.54 We show that DBAA can be used to selectively generate Sec in Cysteine-containing proteins under mild reaction conditions (Fig. 3). This selectivity was demonstrated using SelM because its Sec and Cys are in close proximity, which makes it a challenging target. When the reaction was carried out at pH 6.5, over 95% of Sec were deselenized to dehydroalanine, as is apparent from the mass loss of 81 Da compared to that of the unreacted protein (Fig. 3a-b), corresponding to a selenium atom and two protons. When the sample containing dehydroalanine was incubated with the alkylating reagent iodoacetamide the protein acquired a mass of 57 Da, which corresponds to Cys45 alkylation with one iodoacetamide, demonstrating that the Cys remained exposed and available for labeling (Fig. 3c-d). Reactions at higher pH were not selective to Sec and instead targeted both Cys and Sec as expected based on their pKa (Fig. S29). Hence, Sec-EPL allows introducing dehydroalanine selectively in proteins that contain cysteines as long as the reaction pH is poised lower than the cysteines’ pKa (Fig. S30). This demonstrates that Sec-mediated ligation and conversion to dehydroalanine can be applied broadly for the incorporation of diverse post-translational modifications. Furthermore, if the labeling reaction with dehydroalanine is carried out at pH <7, then additional conjugates can be introduced by modifying cysteines at a higher pH in a separate step.
Figure 3.
Chemoselective dehydroalanine formation from Sec. (a) Sec deselenization into dehydroalanine can be promoted through two successive alkylation steps. The reaction can be carried out selectively, even when cysteines are present, due to difference between Sec and Cys pKas. (b) Dehydroalanine formation in SelM at pH 6.5 showing complete conversion. (c) The sample from panel b treated with excess iodoacetamide at pH 7.0. The sole Cys was available for alkylation at that pH even though it was in proximity to the dehydroalanine site. (d) Tandem mass of trypsin-digested sample from panel c further confirms the presence of dehydroalanine in position 48. Red color indicates ions containing dehydroalanine. The purple star denotes alkylation by iodoacetamide.
Discussion
Sec-EPL is as straightforward to implement as Cys-mediated EPL but offers higher ligation efficiency by allowing the reaction’s pH to be lower than 7, which minimizes the competing thioester hydrolysis. In addition, this method offers the highest flexibility for the choice of conjugation site among all EPL approaches because deselenization is selective over desulfurization, allowing Cys in the protein to be retained.8,9 It also requires milder reagents than desulfurization, which do not damage the protein. For bioconjugations and posttranslational modifications the Sec provides a site-specific handle for chemical conjugation that can be selectively targeted over other residues. These advantages are well documented for ligation with seleno-peptides but are here enabled for research with heterologous Sec-containing proteins extending the range of possible targets. The approach is robust without a need to optimize expression or purification conditions for different targets. It is also compatible with both denaturing and native conditions, which can be helpful in assembly of proteins from respective pieces. Such multi-step ligations are popular for Cys-driven peptide ligations of complex proteins,55 but not for proteins due to low yield. Yet, it is a powerful approach for introducing multiple post-translational modifications and bioconjugates in different positions into the protein scaffold.
Here, our Sec-EPL method was introduced for proteins that contain no native cysteines past the Sec, as the currently utilized incorporation method would replace native cysteines in the C-terminal segment of the protein with Sec. Because cysteines’ low abundance a large number of proteins will not be affected by this issue. However, to extend the methodology to proteins that are affected, purification of the desired seleno-fragment based either on differences in Sec and Cys’s pKa or variances in the rates of covalent bonds formation could be utilized. Nevertheless, we believe that multi-step reactions - building proteins through multiple ligation steps - would provide a more general solution to this limitation. To that end, the high ligation efficiencies presented here provide a promising first step.
Sec-EPL enables the introduction of Sec residues and thus selenylsulfide and diselenide bonds in proteins to generate new functions or folding paths.56 The experiments presented here demonstrate the application of Sec-EPL for production of both naturally occurring and engineered selenoproteins. In particular, we show the successful production of several members of the large class of selenoproteins with a thioredoxin fold,57 which can currently only be prepared by techniques that require expert knowledge such as total chemical synthesis34 and engineered Sec-specific tRNAs.27–30 Due to the high yields of the procedure all preparations resulted in sufficient amounts for the proteins’ biochemical and biophysical characterization. Such information will be valuable for identifying selenoproteins’ enzymatic functions, the contribution of Sec, their roles in sensing and signaling of oxidative stress and potentially new applications.
In addition we have demonstrated the broad applicability to non-selenoproteins. We have taken advantage of Sec’s unique chemistry and known reactivity, which offers paths for site-specific incorporation of bioconjugations, and the coupling of two proteins. As we have shown here Sec-EPL is compatible with the presence of cysteines and it is possible to adjust the reactions conditions to preferentially label Sec. As we have shown here, Sec can be used to reversibly introduce bioconjugates via selenylsulfide and diselenide bonds and irreversibly via selenoether bonds. We have also demonstrated a selective generation of dehydroalanine from Sec in proteins containing Cys with no damage to other residues under biocompatible conditions. The ability to generate it in proteins with multiple cysteines without the need to rely on unnatural amino acid formation should be advantageous for downstream applications including introducing post-translational modifications that closely resemble those that occur in vivo, e.g. similar charge, length and conformational degrees of freedom. Therefore, Sec-EPL can be used to incorporate multiple post-translational modifications by manipulation of Sec and Cys residues in proteins.
In conclusion, our work provides new tools for preparing and modifying proteins. The Sec-EPL procedure is versatile, robust, straightforward to implement and requires no synthesis or special expertise with selenium chemistry. Overall, Sec-EPL extends the ease and generality of biosynthetic protein preparations, the class of proteins that can be prepared, and offers new avenues to exploit Sec’s high chemical reactivity.
Supplementary Material
Acknowledgments
We thank Drs. Colin Thorpe and Joe Fox for helpful discussions and Dr. Zhihao Zhuang for generous contribution of DBAA for initial tests. The Delaware COBRE program supported this project with grants from the National Institute of General Medical Sciences – NIGMS (5 P30 GM110758-02 and 5 P20 GM104316) from the National Institutes of Health. This work was primarily supported by the National Science Foundation under Grant No. MCB-1054447 “CAREER: Reactivity of Selenoproteins” and Grant No. MCB-1616178.
Footnotes
Supporting Information. The Supporting Information is available free of charge on the ACS Publications website. It contains details on the experimental methods used in this manuscript, addgene plasmid numbers, the expression, purification and characterization of protein fragments, as well as the selective generation of dehydroalanine and protein tagging.
Notes
The authors declare no competing financial interest.
References
- 1.Dawson PE, Muir TW, Clark-Lewis I, Kent SB. Science. 1994;266:776. doi: 10.1126/science.7973629. [DOI] [PubMed] [Google Scholar]
- 2.Muir TW, Sondhi D, Cole PA. Proc Natl Acad Sci USA. 1998;95:6705. doi: 10.1073/pnas.95.12.6705. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Muir TW. Annu Rev Biochem. 2003;72:249. doi: 10.1146/annurev.biochem.72.121801.161900. [DOI] [PubMed] [Google Scholar]
- 4.Muralidharan V, Muir TW. Nat Methods. 2006;3:429. doi: 10.1038/nmeth886. [DOI] [PubMed] [Google Scholar]
- 5.McGrath NA, Raines RT. Acc Chem Res. 2011;44:752. doi: 10.1021/ar200081s. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Arnér ESJ. Exp Cell Res. 2010;316:1296. doi: 10.1016/j.yexcr.2010.02.032. [DOI] [PubMed] [Google Scholar]
- 7.Reich HJ, Hondal RJ. ACS Chem Biol. 2016;11:821. doi: 10.1021/acschembio.6b00031. [DOI] [PubMed] [Google Scholar]
- 8.Wan Q, Danishefsky SJ. Angew Chem Int Ed Engl. 2007;46:9248. doi: 10.1002/anie.200704195. [DOI] [PubMed] [Google Scholar]
- 9.Metanis N, Keinan E, Dawson PE. Angew Chem. 2010;49:7049. doi: 10.1002/anie.201001900. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Dery S, Reddy PS, Dery L, Mousa R, Dardashti RN, Metanis N. Chem Sci. 2015;6:6207. doi: 10.1039/c5sc02528a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Malins LR, Mitchell NJ, McGowan S, Payne RJ. Angew Chem. 2015;54:12716. doi: 10.1002/anie.201504639. [DOI] [PubMed] [Google Scholar]
- 12.Chalker JM, Gunnoo SB, Boutureira O, Gerstberger SC, Fernandez-Gonzalez M, Bernardes GJL, Griffin L, Hailu H, Schofield CJ, Davis BG. Chem Sci. 2011;2:1666. [Google Scholar]
- 13.Cheng Q, Johansson L, Thorell JO, Fredriksson A, Samen E, Stone-Elander S, Arner ESJ. ChemBioChem. 2006;7:1976. doi: 10.1002/cbic.200600326. [DOI] [PubMed] [Google Scholar]
- 14.Wang J, Schiller SM, Schultz PG. Angew Chem Int Ed Engl. 2007;46:6849. doi: 10.1002/anie.200702305. [DOI] [PubMed] [Google Scholar]
- 15.Pedzisa L, Li X, Rader C, Roush WR. Org Biomol Chem. 2016;14:5141. doi: 10.1039/c6ob00775a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Li X, Patterson JT, Sarkar M, Pedzisa L, Kodadek T, Roush WR, Rader C. Bioconj Chem. 2015;26:2243. doi: 10.1021/acs.bioconjchem.5b00244. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Boutureira O, Bernardes GJ, Fernandez-Gonzalez M, Anthony DC, Davis BG. Angew Chem Int Ed Engl. 2012;51:1432. doi: 10.1002/anie.201106658. [DOI] [PubMed] [Google Scholar]
- 18.Quaderer R, Sewing A, Hilvert D. Helv Chim Acta. 2001;84:1197. [Google Scholar]
- 19.Gieselman MD, Xie L, van Der Donk WA. Org Lett. 2001;3:1331. doi: 10.1021/ol015712o. [DOI] [PubMed] [Google Scholar]
- 20.Hondal RJ, Nilsson BL, Raines RT. J Am Chem Soc. 2001;123:5140. doi: 10.1021/ja005885t. [DOI] [PubMed] [Google Scholar]
- 21.Hondal RJ. Protein Peptide Lett. 2005;12:757. doi: 10.2174/0929866054864319. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Metanis N, Keinan E, Dawson PE. J Am Chem Soc. 2006;128:16684. doi: 10.1021/ja0661414. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Hondal RJ. Biochim Biophys Acta. 2009;1790:1501. doi: 10.1016/j.bbagen.2009.04.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Hatfield DL, Tsuji PA, Carlson BA, Gladyshev VN. Trends Biochem Sci. 2014;39:112. doi: 10.1016/j.tibs.2013.12.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Labunskyy VM, Hatfield DL, Gladyshev VN. Physiol Rev. 2014;94:739. doi: 10.1152/physrev.00039.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Arnér ESJ, Sarioglu H, Lottspeich F, Holmgren A, Bock A. J Mol Biol. 1999;292:1003. doi: 10.1006/jmbi.1999.3085. [DOI] [PubMed] [Google Scholar]
- 27.Aldag C, Bröcker MJ, Hohn MJ, Prat L, Hammond G, Plummer A, Söll D. Angew Chem. 2013;52:1441. doi: 10.1002/anie.201207567. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Thyer R, Filipovska A, Rackham O. J Am Chem Soc. 2013;135:2. doi: 10.1021/ja3069177. [DOI] [PubMed] [Google Scholar]
- 29.Thyer R, Robotham SA, Brodbelt JS, Ellington AD. J Am Chem Soc. 2015;137:46. doi: 10.1021/ja510695g. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Miller C, Brocker MJ, Prat L, Ip K, Chirathivat N, Feiock A, Veszpremi M, Soll D. FEBS Lett. 2015;589:2194. doi: 10.1016/j.febslet.2015.06.039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Rakauskaite R, Urbanaviciute G, Ruksenaite A, Liutkeviciute Z, Juskenas R, Masevicius V, Klimasauskas S. Chem Commun. 2015;51:8245. doi: 10.1039/c4cc07910h. [DOI] [PubMed] [Google Scholar]
- 32.Schaefer SA, Dong M, Rubenstein RP, Wilkie WA, Bahnson BJ, Thorpe C, Rozovsky S. J Mol Biol. 2013;425:222. doi: 10.1016/j.jmb.2012.11.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Wang YJ, Szantai-Kis DM, Petersson EJ. Org Biomol Chem. 2016;14:6262. doi: 10.1039/c6ob01020b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Dery L, Reddy PS, Dery S, Mousa R, Ktorza O, Talhami A, Metanis N. Chem Sci. 2017 doi: 10.1039/c6sc04123j. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Muller S, Senn H, Gsell B, Vetter W, Baron C, Bock A. Biochemistry. 1994;33:3404. doi: 10.1021/bi00177a034. [DOI] [PubMed] [Google Scholar]
- 36.Strub MP, Hoh F, Sanchez JF, Strub JM, Bock A, Aumelas A, Dumas C. Structure. 2003;11:1359. doi: 10.1016/j.str.2003.09.014. [DOI] [PubMed] [Google Scholar]
- 37.Salgado PS, Taylor JD, Cota E, Matthews SJ. Acta Crystallogr D. 2011;67:8. doi: 10.1107/S0907444910042022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Liu J, Rozovsky S. Antioxid Redox Signal. 2015;23:795. doi: 10.1089/ars.2015.6388. [DOI] [PubMed] [Google Scholar]
- 39.Martin JL. Structure. 1995;3:245. doi: 10.1016/s0969-2126(01)00154-x. [DOI] [PubMed] [Google Scholar]
- 40.Atkinson HJ, Babbitt PC. PLoS Comput Biol. 2009;5:e1000541. doi: 10.1371/journal.pcbi.1000541. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Kasaikina MV, Hatfield DL, Gladyshev VN. Biochim Biophys Acta. 2012;1823:1633. doi: 10.1016/j.bbamcr.2012.02.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Ferguson AD, Labunskyy VM, Fomenko DE, Araç D, Chelliah Y, Amezcua CA, Rizo J, Gladyshev VN, Deisenhofer J. J Biol Chem. 2006;281:3536. doi: 10.1074/jbc.M511386200. [DOI] [PubMed] [Google Scholar]
- 43.Kapust RB, Tozser J, Copeland TD, Waugh DS. Biochem Biophys Res Commun. 2002;294:949. doi: 10.1016/S0006-291X(02)00574-0. [DOI] [PubMed] [Google Scholar]
- 44.Chong S, Williams KS, Wotkowicz C, Xu MQ. J Biol Chem. 1998;273:10567. doi: 10.1074/jbc.273.17.10567. [DOI] [PubMed] [Google Scholar]
- 45.Aachmann FL, Fomenko DE, Soragni A, Gladyshev VN, Dikiy A. J Biol Chem. 2007;282:37036. doi: 10.1074/jbc.M705410200. [DOI] [PubMed] [Google Scholar]
- 46.Alkan Z, Duong FL, Hawkes WC. Biochim Biophys Acta Mol Cell Biol L. 2015;1853:1087. doi: 10.1016/j.bbamcr.2015.02.016. [DOI] [PubMed] [Google Scholar]
- 47.Hsu CH, Shen TL, Chang CF, Chang YY, Huang LY. PLoS One. 2012;7 doi: 10.1371/journal.pone.0052292. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Gu QP, Beilstein MA, Barofsky E, Ream W, Whanger PD. Arch Biochem Biophys. 1999;361:25. doi: 10.1006/abbi.1998.0949. [DOI] [PubMed] [Google Scholar]
- 49.Wessjohann LA, Schneider A, Abbas M, Brandt W. Biol Chem. 2007;388:997. doi: 10.1515/BC.2007.138. [DOI] [PubMed] [Google Scholar]
- 50.Lin YA, Boutureira O, Lercher L, Bhushan B, Paton RS, Davis BG. J Am Chem Soc. 2013;135:12156. doi: 10.1021/ja403191g. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Wright TH, Bower BJ, Chalker JM, Bernardes GJ, Wiewiora R, Ng WL, Raj R, Faulkner S, Vallee MR, Phanumartwiwath A, Coleman OD, Thezenas ML, Khan M, Galan SR, Lercher L, Schombs MW, Gerstberger S, Palm-Espling ME, Baldwin AJ, Kessler BM, Claridge TD, Mohammed S, Davis BG. Science. 2016;354 doi: 10.1126/science.aag1465. [DOI] [PubMed] [Google Scholar]
- 52.Boutureira O, Bernardes GJL. Chem Rev. 2015;115:2174. doi: 10.1021/cr500399p. [DOI] [PubMed] [Google Scholar]
- 53.Yang A, Ha S, Ahn J, Kim R, Kim S, Lee Y, Kim J, Soll D, Lee HY, Park HS. Science. 2016;354:623. doi: 10.1126/science.aah4428. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Whedon SD, Markandeya N, Rana AS, Weller CE, Senger NA, Turecek F, Strieter ER, Chatterjee C. J Am Chem Soc. 2016;138:13774. doi: 10.1021/jacs.6b05688. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Raibaut L, Ollivier N, Melnyk O. Chem Soc Rev. 2012;41:7001. doi: 10.1039/c2cs35147a. [DOI] [PubMed] [Google Scholar]
- 56.Metanis N, Hilvert D. Curr Opin Chem Biol. 2014;22:27. doi: 10.1016/j.cbpa.2014.09.010. [DOI] [PubMed] [Google Scholar]
- 57.Lu J, Holmgren A. J Biol Chem. 2009;284:723. doi: 10.1074/jbc.R800045200. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.